Dr Ing hcF Porsche AG
Dr. Ing. h.c. F. Porsche AG engages in automotive and financial services business in Germany, rest of Europe, North America, China, and internationally. The company procures, develops, manufactures, and sells vehicles, as well as provides related services. It also offers leasing, dealer and customer financing, insurance brokerage, mobility, and other finance-related services. The company was form… Read more
Dr Ing hcF Porsche AG (P911) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.027x
Based on the latest financial reports, Dr Ing hcF Porsche AG (P911) has a cash flow conversion efficiency ratio of 0.027x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€626.00 Million) by net assets (€23.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Dr Ing hcF Porsche AG - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Dr Ing hcF Porsche AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Dr Ing hcF Porsche AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dr Ing hcF Porsche AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT GoTo Gojek Tokopedia Tbk
F:CK8
|
N/A |
|
NetScout Systems Inc
NASDAQ:NTCT
|
0.038x |
|
Dream Industrial Real Estate Investment Trust
PINK:DREUF
|
0.012x |
|
TowneBank
F:3T8
|
0.022x |
|
Enka Insaat ve Sanayi A.S
OTCGREY:EKIVF
|
0.022x |
|
Dave Inc
NASDAQ:DAVE
|
0.265x |
|
Hellenic Telec
LSE:0FIZ
|
0.110x |
|
Hisamitsu Pharmaceutical Co. Inc
F:HPX
|
N/A |
Annual Cash Flow Conversion Efficiency for Dr Ing hcF Porsche AG (2019–2024)
The table below shows the annual cash flow conversion efficiency of Dr Ing hcF Porsche AG from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €23.06 Billion | €6.35 Billion | 0.276x | -14.99% |
| 2023-12-31 | €21.67 Billion | €7.02 Billion | 0.324x | -22.42% |
| 2022-12-31 | €17.03 Billion | €7.11 Billion | 0.418x | +49.35% |
| 2021-12-31 | €22.93 Billion | €6.42 Billion | 0.280x | +36.66% |
| 2020-12-31 | €20.22 Billion | €4.14 Billion | 0.205x | -20.47% |
| 2019-12-31 | €17.43 Billion | €4.49 Billion | 0.257x | -- |